Details for New Drug Application (NDA): 200149
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 200149
Tradename: | SILDENAFIL CITRATE |
Applicant: | Actavis Grp Ptc |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 200149
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Feb 25, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription